Follow this preprint
Effectiveness Over Time of a Primary Series of the Original Monovalent COVID-19 Vaccines in Adults in the United States
View ORCID ProfileJ. Bradley Layton, View ORCID ProfilePatricia C. Lloyd, View ORCID ProfileLauren S. Peetluk, View ORCID ProfileYixin Jiao, View ORCID ProfileDjeneba Audrey Djibo, View ORCID ProfileJoann F. Gruber, View ORCID ProfileJie Deng, View ORCID ProfileChristine Bui, View ORCID ProfileAn-Chi Lo, View ORCID ProfileRachel P. Ogilvie, Ron Parambi, Michael Miller, Jennifer Song, Lisa B. Weatherby, View ORCID ProfileSylvia Cho, View ORCID ProfileHui Lee Wong, Tainya C. Clarke, View ORCID ProfileJessica Rose Hervol, Dóra Illei, Elizabeth J. Bell, View ORCID ProfileGrace Wenya Yang, View ORCID ProfileJohn D. Seeger, View ORCID ProfileMichael Wernecke, View ORCID ProfileMorgan M. Richey, View ORCID ProfileRichard A. Forshee, Steven A. Anderson, View ORCID ProfileYoganand Chillarige, View ORCID ProfileCheryl N. McMahill-Walraven, View ORCID ProfileKandace L. Amend, View ORCID ProfileMary S. Anthony, Azadeh Shoaibi
doi: https://doi.org/10.1101/2024.07.24.24310878
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
J. Bradley Layton
1RTI Health Solutions, Research Triangle Park, North Carolina, United States
Patricia C. Lloyd
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Lauren S. Peetluk
3Optum Epidemiology, Boston, MA, United States
Yixin Jiao
4Acumen LLC, Burlingame, CA, United States
Djeneba Audrey Djibo
5CVS Health, Safety Surveillance & Collaboration, Blue Bell, PA, United States
Joann F. Gruber
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Jie Deng
3Optum Epidemiology, Boston, MA, United States
Christine Bui
1RTI Health Solutions, Research Triangle Park, North Carolina, United States
An-Chi Lo
4Acumen LLC, Burlingame, CA, United States
Rachel P. Ogilvie
3Optum Epidemiology, Boston, MA, United States
Ron Parambi
3Optum Epidemiology, Boston, MA, United States
Michael Miller
3Optum Epidemiology, Boston, MA, United States
Jennifer Song
3Optum Epidemiology, Boston, MA, United States
Lisa B. Weatherby
3Optum Epidemiology, Boston, MA, United States
Sylvia Cho
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Hui Lee Wong
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Tainya C. Clarke
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Jessica Rose Hervol
4Acumen LLC, Burlingame, CA, United States
Dóra Illei
6RTI International, Washington, DC, United States
Elizabeth J. Bell
3Optum Epidemiology, Boston, MA, United States
Grace Wenya Yang
7OptumServe, Falls Church, VA, United States
John D. Seeger
3Optum Epidemiology, Boston, MA, United States
Michael Wernecke
4Acumen LLC, Burlingame, CA, United States
Morgan M. Richey
1RTI Health Solutions, Research Triangle Park, North Carolina, United States
Richard A. Forshee
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Steven A. Anderson
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States
Yoganand Chillarige
4Acumen LLC, Burlingame, CA, United States
Cheryl N. McMahill-Walraven
5CVS Health, Safety Surveillance & Collaboration, Blue Bell, PA, United States
Kandace L. Amend
3Optum Epidemiology, Boston, MA, United States
Mary S. Anthony
1RTI Health Solutions, Research Triangle Park, North Carolina, United States
Azadeh Shoaibi
2US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, United States

Posted July 24, 2024.
Effectiveness Over Time of a Primary Series of the Original Monovalent COVID-19 Vaccines in Adults in the United States
J. Bradley Layton, Patricia C. Lloyd, Lauren S. Peetluk, Yixin Jiao, Djeneba Audrey Djibo, Joann F. Gruber, Jie Deng, Christine Bui, An-Chi Lo, Rachel P. Ogilvie, Ron Parambi, Michael Miller, Jennifer Song, Lisa B. Weatherby, Sylvia Cho, Hui Lee Wong, Tainya C. Clarke, Jessica Rose Hervol, Dóra Illei, Elizabeth J. Bell, Grace Wenya Yang, John D. Seeger, Michael Wernecke, Morgan M. Richey, Richard A. Forshee, Steven A. Anderson, Yoganand Chillarige, Cheryl N. McMahill-Walraven, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi
medRxiv 2024.07.24.24310878; doi: https://doi.org/10.1101/2024.07.24.24310878
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (409)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3058)
- Dermatology (258)
- Emergency Medicine (458)
- Epidemiology (12990)
- Forensic Medicine (13)
- Gastroenterology (855)
- Genetic and Genomic Medicine (4795)
- Geriatric Medicine (442)
- Health Economics (748)
- Health Informatics (3041)
- Health Policy (1098)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (495)
- Neurology (4568)
- Nursing (243)
- Nutrition (675)
- Oncology (2370)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1234)
- Primary Care Research (516)
- Public and Global Health (7153)
- Radiology and Imaging (1590)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (399)
- Surgery (506)
- Toxicology (64)
- Transplantation (218)
- Urology (188)